Keyphrases
Polyneuropathy
100%
Intravenous Immunoglobulin (IVIg)
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Data Combination
100%
Privigen
100%
Hizentra
100%
Inflammatory Neuropathy
60%
Adverse Drug Reaction
40%
Treatment Efficacy
30%
Pooled Cohorts
30%
Grip Strength
20%
Medical Research Council
20%
Treatment Measures
20%
IgPro10
20%
Efficacy Assessment
10%
Demographic Differences
10%
Single-arm Study
10%
Double-blind Randomized Study
10%
Potential Therapy
10%
FDA-approved Drugs
10%
Nave
10%
Immunoglobulin
10%
Median Time
10%
Change from Baseline
10%
Maximum Grip
10%
Restabilization
10%
Treatment Improvement
10%
Online Publication
10%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Human Immunoglobulin
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Polyneuropathy
100%
Neuropathy
54%
Adverse Drug Reaction
36%
Efficacy Assessment
9%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Human Immunoglobulin
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Drug Hypersensitivity
36%
Arm
18%
Grip Strength
18%
Neuroscience
Polyneuropathy
100%
Intravenous Immunoglobulin
100%
Human Immunoglobulin
100%
Neuropathy
54%
Biochemistry, Genetics and Molecular Biology
Intravenous Immunoglobulin
100%
Grip Strength
18%
Efficacy Assessment
9%